Related references
Note: Only part of the references are listed.The HPV E6/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets
Karin Hoppe-Seyler et al.
TRENDS IN MICROBIOLOGY (2018)
Involvement of Brd4 in different steps of the papillomavirus life cycle
Thomas Iftner et al.
VIRUS RESEARCH (2017)
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
Denise Martinez-Zapien et al.
NATURE (2016)
Tandemly Integrated HPV16 Can Form a Brd4-Dependent Super-Enhancer-Like Element That Drives Transcription of Viral Oncogenes
Katharine E. Dooley et al.
MBIO (2016)
The role of DNA damage responses in p53 biology
Daniel Speidel
ARCHIVES OF TOXICOLOGY (2015)
Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
Pawel K. Mazur et al.
NATURE MEDICINE (2015)
Human papillomavirus (HPV) screening and cervical cancer burden. A Brazilian perspective
Adriana T. Lorenzi et al.
VIROLOGY JOURNAL (2015)
The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy
Ketaki Ganti et al.
VIRUSES-BASEL (2015)
Inhibition of bromodomain and extraterminal proteins (BET) as a potential therapeutic approach in haematological malignancies: emerging preclinical and clinical evidence
Aristeidis Chaidos et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2015)
Privileged Diazepine Compounds and Their Emergence as Bromodomain Inhibitors
Steven G. Smith et al.
CHEMISTRY & BIOLOGY (2014)
Human papillomavirus oncoproteins and apoptosis (Review)
Peiyue Jiang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
New molecular targets against cervical cancer
Alfonso Duenas-Gonzalez et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2014)
High-Risk Human Papillomaviruses Repress Constitutive Kappa Interferon Transcription via E6 To Prevent Pathogen Recognition Receptor and Antiviral-Gene Expression
Jeanette Reiser et al.
JOURNAL OF VIROLOGY (2011)
cIAP2 Upregulated by E6 Oncoprotein via Epidermal Growth Factor Receptor/Phosphatidylinositol 3-Kinase/AKT Pathway Confers Resistance to Cisplatin in Human Papillomavirus 16/18-Infected Lung Cancer
Heng-Hsiung Wu et al.
CLINICAL CANCER RESEARCH (2010)
The Full-Length Isoform of Human Papillomavirus 16 E6 and Its Splice Variant E6*Bind to Different Sites on the Procaspase 8 Death Effector Domain
Sandy S. Tungteakkhun et al.
JOURNAL OF VIROLOGY (2010)
Abrogation of the Brd4-Positive Transcription Elongation Factor b Complex by Papillomavirus E2 Protein Contributes to Viral Oncogene Repression
Junpeng Yan et al.
JOURNAL OF VIROLOGY (2010)
Selective inhibition of BET bromodomains
Panagis Filippakopoulos et al.
NATURE (2010)
Papillomaviruses in the causation of human cancers - a brief historical account
Harald zur Hausen
VIROLOGY (2009)
The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation
Shwu-Yuan Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity
Maria Filippova et al.
JOURNAL OF VIROLOGY (2007)
Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis
T. O. Garnett et al.
CELL DEATH AND DIFFERENTIATION (2006)
Comparative analysis of 19 genital human papillomavirus types with regard to p53 degradation, immortalization, phylogeny, and epidermiologic risk classification
Thomas Hiller et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription
MK Jang et al.
MOLECULAR CELL (2005)
Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein brd4
ZY Yang et al.
MOLECULAR CELL (2005)
Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis
HD Yuan et al.
ONCOGENE (2005)
Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: A gynecologic oncology group study
HJ Long et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells
P Laprise et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex
L Gewin et al.
GENES & DEVELOPMENT (2004)
The human papillomavirus 16 E6 protein binds to Fas-associated death domain and protects cells from Fas-triggered apoptosis
M Filippova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cisplatin: mode of cytotoxic action and molecular basis of resistance
ZH Siddik
ONCOGENE (2003)
The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis
M Filippova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Share Paper
